StockSelector.com
  Research, Select, & Monitor Sunday, September 20, 2020 3:16:28 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Recro Pharma, Inc$2.48$.145.98%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Recro Pharma, Inc has an overall rank of 5542 out of 7562 stocks based on 7 positive rankings and 8 negative rankings.

Positive Rankings
Low Put/Call
Recro Pharma has a low Put/Call ratio of 0.04 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Recro Pharma is ranked 189.
SSValue
The StockSelector Value for Recro Pharma is $10.71. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Recro Pharma is ranked 289.
Low vPut/Call
Recro Pharma has a low Put/Call ratio of 0.11 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Recro Pharma is ranked 319.
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Recro Pharma is ranked 461.
PEGValue
Recro Pharma has a PEG Value of $2.43. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain -1.92% in the next year. Among companies with a PEG Value above the current stock price, Recro Pharma is ranked 840.
10 Day Gain
Recro Pharma rank is 986
Price-to-Sales
Recro Pharma rank is 1109
Negative Rankings
Negative Guidance
Within the past 90 days Recro Pharma has provided guidance belwo the consensus estimates. Statistics show companies that provide negative guidance underperform the market in the short-term.
90 Day Loss
Recro Pharma rank is 138
Negative EPS Growth
Recro Pharma rank is 435
Down EPS Surprise
Recro Pharma missed the consensus earnings estimate when it last reported quarterly earnings.
Negative Revenue Estimate
Recro Pharma rank is 588
Negative Cash Growth
Recro Pharma rank is 711
Negative Net Margin
Recro Pharma rank is 970
Negative ROA
Recro Pharma rank is 1068







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2020 StockSelector.com. All rights reserved.